CClinicalTrials.gg
Status unknownNCT03249805mFABUpdated Aug 17, 2018

MiracleFeet Foot Abduction Brace Sensor Trial

An interventional study of Steenbeek Foot Abduction Brace (SFAB) and MiracleFeet Foot Abduction Brace (mFAB) in Clubfoot, Telemedicine and Patient Compliance, sponsored by MiracleFeet. Status unknown at 1 site in India. Open to participants aged 3 Months to 1 Year. Per ClinicalTrials.gov, last updated 2018-08-17.

Sponsored by MiracleFeet · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
3 Months to 1 Year
Sex
All
01

Study summary

The aim of this study is to determine the effect of a new design of FAB type on compliance and treatment outcomes of idiopathic clubfeet treated by the Ponseti method. Very little literature exists on the effect of brace type or the difference between reported and actual at-home compliance, which is integral to the success of treatment with the Ponseti method. Eighty children less than 1 year of age will be enrolled in the study into two arms, using block randomization. These two groups will use two different designs of foot abduction brace (FAB). Outcomes will be measured by number of recurrences per group (using recasting and/or surgical procedures and Pirani score as indicators), time of recurrences (in months), compliance with brace wear using sensors and comparing the data with brace wear reported by parents, and parent satisfaction with FAB (measured on a modified Orthotics and Prosthetics User Sur vey). Enrollment will be on a rolling basis; subjects will be enrolled at their last cast application and followed for approximately 6 months. Recurrences, time of recurrence, parent satisfaction, and reported vs. actual compliance will be analyzed.

Read the detailed description

Clubfoot is the most common birth defect affecting 1 in every 750 live births, that is about 200,000 babies each year globally (80% mainly in developing countries). An estimated average 1 million children are currently living with untreated clubfoot. In India every 10 minutes a child is born with clubfoot i.e. over 50,000 children are born with this deformity every year (1 per 500 birth). The Ponseti Method is now recognized as the accepted standard for the medical treatment of clubfoot. The Ponseti Method is ideally suited for the developing world in that it is inexpensive, non-surgical and the casting component can be completed by trained medical and paramedical personnel. Clubfoot causes the feet of the affected individual to point downward and inward. Left untreated, clubfoot causes a permanent physical disability, preventing the individual from walking normally and limiting his or her mobility. Decreased ambulation can lead to the inability to perform daily tasks, such as going to school, leading to increased dependency and a negative economic impact on the family. Furthermore, deformity caused by neglected clubfoot can lead to limited social integration and stigma for both the individual and the family.

The gold standard of clubfoot treatment is the Ponseti method, which consists of 6-8 weeks of serial castings followed by a percutaneous Tendo Achilles tenotomy in the majority of cases. The casting is followed by the use of a foot abduction brace (FAB) for approximately 4 years. The goal of the treatment is to correct the deformity so that the patient has a functional, painless, plantigrade foot with full mobility without the need for orthotics. The 6-8 weeks of serial casting corrects the clubfoot deformity while the use of the FAB after casting prevents the deformity from reoccurring and is required for successful treatment. Noncompliance of FAB use increases the risk of relapse 17-fold.

Currently, the Steenbeek Foot Abduction Brace (SFAB), a version of the Denis Browne splint, is the only low-cost FAB available. The SFAB is made by hand by artisans, limiting its large-scale production. Furthermore, it can be challenging to put on a child due to the shoes being attached to the bar and lacking a strap in addition to laces, potentially leading to noncompliance.

The more recently developed MiracleFeet Foot Abduction Brace (mFAB) is made of injection molded plastic, making it easy to mass produce, and includes removable shoes with a strap to hold the heel in place, claiming to be more comfortable and easier to use, leading to improved compliance.

The MiracleFeet Foot Abduction Brace (mFAB) is a Denis Browne Splint used for the treatment of clubfoot. Use of the Denis Browne Split is standard in clubfoot treatment and the mFAB complies with the standards for foot abduction braces for clubfoot:

  • Adjustable to 65 and 45 degrees to accommodate unilateral and bilateral clubfoot
  • 10 degrees dorsiflexion

The mFAB was designed with the following additional features, based on requests from parents and providers:

  • Large window to view the heel, ensuring it lays flat in the shoe
  • Dorsal strap to secure the heel, allowing the shoe to be tied with two hands
  • Removable shoes so that the shoes may be applied and then clipped into the bar
  • A flat bottom
  • The bar is made of strong injection-modeled plastic, in order to be reused
  • The shoes are meant to be worn only by 1 child and then discarded

The mFAB shoes are made of canvas and polyester and the bar and shoe plates are made of ortholite and T90 and are manufactured using the injected-molded plastic process in Batavia, Illinois, USA.

The mFAB has been tested in Nicaragua, Brazil, South Africa and the Philippines and is currently in use in 10 countries. Both braces meet the specifications as detailed by the Ponseti method and the same bracing protocol is used for both.

This study will compare treatment outcomes and compliance using the two brace designs, SFAB and mFAB. We will compare the number and time of recurrences, as well as the reported compliance and actual compliance, which will be measured by novel sensors. Few studies exist that compare brace types or actual versus reported compliance and FABs with sensors are a novel technology. Of the literature that exists, FAB use was show to decline significantly during the first 3 months and actual wear is less than reported wear.

02

Conditions studied

  • Clubfoot
  • Telemedicine
  • Patient Compliance

Keywords

  • LMIC
  • Medical device efficacy
03

Who can participate

Ages eligible
3 Months to 1 Year
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Unilateral or bilateral cases of idiopathic clubfoot in children who have not yet started walking at first presentation, receiving a brace for the first time after successful correction with the Ponseti method of treatment, at the Bai Jerbai Wadia Hospital for Children over a period of 6 months.

Exclusion criteria

Exclusion Criteria:

  • All children who are already walking at presentation; All children with previous treatment; All children who have used FAB previously; All children treated with surgery other than tenotomy; All children with syndromic or neuropathic cases of clubfoot; All children with atypical clubfoot.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Steenbeek Foot Abduction Brace (SFAB)

    The study will follow the subject for 6 months after their enrollment, beginning at first FAB use. The Steenbeek Foot Abduction Brace (SFAB) is a fixed metal bar attached to two leather shoes with laces. The shoes have laces and a strap. The FABs provide 10 degrees of dorsiflexion and 45 or 65 degrees of abduction, and will be equipped with sensors to measure at-home FAB compliance. After the last cast is removed, a brace will be worn for 23 hours/day for the first 3 months and the time will be gradually decreased thereafter to a 'nights and naps' protocol for a total of 12 hours/day. At follow-up appointments the brace will be checked for fit and Pirani score recorded.

    Device: Steenbeek Foot Abduction Brace (SFAB)

  • Experimental
    MiracleFeet Foot Abduction Brace (mFAB)

    The study will follow the subject for 6 months after their enrollment, beginning at first FAB use. The MiracleFeet Foot Abduction Brace (mFAB) is an injected plastic molded bar with fabric shoes that clip off and on. The shoes have laces and a strap. Both FABs provide 10 degrees of dorsiflexion and 45 or 65 degrees of abduction, and will be equipped with sensors to measure at-home FAB compliance. After the last cast is removed, a brace will be worn for 23 hours/day for the first 3 months and the time will be gradually decreased thereafter to a 'nights and naps' protocol for a total of 12 hours/day. At follow-up appointments the brace will be checked for fit and Pirani score recorded.

    Device: MiracleFeet Foot Abduction Brace (mFAB)

Interventions

  • DeviceSteenbeek Foot Abduction Brace (SFAB)

    The FAB will be equipped with discretely hidden sensors; subjects and their families will not be aware of the actual function of the sensor in order to avoid increased compliance due to the sensor. Sensors work on the principle of force-sensing resistor material whose resistance changes when a force or pressure is applied. Force-sensing resistors consist of a conductive polymer, which changes resistance in a predictable manner following application of force to its surface. On the top of braces sole we have fixed force resistive sensor (FSR), which changes resistance whenever force is applied. Threshold of detection is 30-40 gram. The changes of resistance is detected by using micro-controller.

    Also known as: Denis Browne splint

  • DeviceMiracleFeet Foot Abduction Brace (mFAB)

    Sensors in the mFAB will measure whether the shoe is on, the foot is in contact with the sole of the shoe and the shoes are clipped into the bar. Sensors work on the principle of force-sensing resistor material whose resistance changes when a force or pressure is applied. Force-sensing resistors consist of a conductive polymer, which changes resistance in a predictable manner following application of force to its surface. On the top of braces sole we have fixed force resistive sensor (FSR), which changes resistance whenever force is applied. Threshold of detection is 30-40 gram. The changes of resistance is detected by using micro-controller.

    Also known as: Denis Browne splint

05

What researchers measure

Primary outcomes

  1. Change in Pirani Score

    The Pirani score is a standardized tool measuring that severity of clubfoot deformity. It will be assessed at all visits - baseline, during treatment and follow-up - to evaluate gradual recurrence of clubfoot deformity.

    Time frame: One year

Secondary outcomes

  1. Orthotics Prosthetics User Survey (OPUS) Results

    Parent satisfaction with the FABs will be determined by administering an OPUS to them at each follow-up visit.

    Time frame: One year

Other outcomes

  1. Minutes of brace usage per day

    To measure at-home brace use compliance, the sensor data will be collected and compared to parent-reported brace usage. This will be tabulated in number of minutes the brace is used per day, collected at each follow-up visit.

    Time frame: One year

06

Study locations

1 of 1 sites recruiting
  • Bai Jerbai Wadia Hospital for Children
    Mumbai, Maharashtra 400012, India
    • Alaric Aroojis, MD · Contact · aaroojis@gmail.com · +91 9320284402
    • Rujuta Mehta, MD · Sub investigator
    • Avi Shah, MD · Sub investigator
    • Nelson Muthu, PhD · Sub investigator
    Recruiting
07

References and documents

Publications

  • Ponseti IV. Treatment of congenital club foot. J Bone Joint Surg Am. 1992 Mar;74(3):448-54. No abstract available. PubMed 1548277 ↗
  • Morcuende JA, Dolan LA, Dietz FR, Ponseti IV. Radical reduction in the rate of extensive corrective surgery for clubfoot using the Ponseti method. Pediatrics. 2004 Feb;113(2):376-80. doi: 10.1542/peds.113.2.376. PubMed 14754952 ↗
  • Morgenstein A, Davis R, Talwalkar V, Iwinski H Jr, Walker J, Milbrandt TA. A randomized clinical trial comparing reported and measured wear rates in clubfoot bracing using a novel pressure sensor. J Pediatr Orthop. 2015 Mar;35(2):185-91. doi: 10.1097/BPO.0000000000000205. PubMed 24787312 ↗
  • Zionts LE, Frost N, Kim R, Ebramzadeh E, Sangiorgio SN. Treatment of idiopathic clubfoot: experience with the Mitchell-Ponseti brace. J Pediatr Orthop. 2012 Oct-Nov;32(7):706-13. doi: 10.1097/BPO.0b013e3182694f4d. PubMed 22955535 ↗
  • Boehm S, Sinclair M. Foot abduction brace in the Ponseti method for idiopathic clubfoot deformity: torsional deformities and compliance. J Pediatr Orthop. 2007 Sep;27(6):712-6. doi: 10.1097/BPO.0b013e3181425508. PubMed 17717477 ↗
  • Chen RC, Gordon JE, Luhmann SJ, Schoenecker PL, Dobbs MB. A new dynamic foot abduction orthosis for clubfoot treatment. J Pediatr Orthop. 2007 Jul-Aug;27(5):522-8. doi: 10.1097/bpo.0b013e318070cc19. PubMed 17585260 ↗
  • Garg S, Porter K. Improved bracing compliance in children with clubfeet using a dynamic orthosis. J Child Orthop. 2009 Aug;3(4):271-6. doi: 10.1007/s11832-009-0182-9. Epub 2009 Jun 3. PubMed 19495824 ↗
  • Hemo Y, Segev E, Yavor A, Ovadia D, Wientroub S, Hayek S. The influence of brace type on the success rate of the Ponseti treatment protocol for idiopathic clubfoot. J Child Orthop. 2011 Apr;5(2):115-9. doi: 10.1007/s11832-010-0321-3. Epub 2010 Dec 24. PubMed 22468155 ↗
  • Janicki JA, Wright JG, Weir S, Narayanan UG. A comparison of ankle foot orthoses with foot abduction orthoses to prevent recurrence following correction of idiopathic clubfoot by the Ponseti method. J Bone Joint Surg Br. 2011 May;93(5):700-4. doi: 10.1302/0301-620X.93B5.24883. PubMed 21511939 ↗
  • Kessler JI. A new flexible brace used in the Ponseti treatment of talipes equinovarus. J Pediatr Orthop B. 2008 Sep;17(5):247-50. doi: 10.1097/BPB.0b013e32830cc3e5. PubMed 19471177 ↗
  • Sangiorgio SN, Ho NC, Morgan RD, Ebramzadeh E, Zionts LE. The Objective Measurement of Brace-Use Adherence in the Treatment of Idiopathic Clubfoot. J Bone Joint Surg Am. 2016 Oct 5;98(19):1598-1605. doi: 10.2106/JBJS.16.00170. PubMed 27707845 ↗
  • Thatipelli S, Arun A, Chung P, Etemadi M, Heller J, Kwiat D et al. Review of Existing Brace Adherence Monitoring Methods to Assess Adherence. Journal of Prosthetics and Orthotics. 2016;28(4):126-135.
  • Manousaki E, Czuba T, Hagglund G, Mattsson L, Andriesse H. Evaluation of gait, relapse and compliance in clubfoot treatment with custom-made orthoses. Gait Posture. 2016 Oct;50:8-13. doi: 10.1016/j.gaitpost.2016.08.005. Epub 2016 Aug 7. PubMed 27544063 ↗
  • Chong DY, Finberg NS, Conklin MJ, Doyle JS, Khoury JG, Gilbert SR. Prospective evaluation of the use of Mitchell shoes and dynamic abduction brace for idiopathic clubfeet. J Pediatr Orthop B. 2014 Nov;23(6):501-4. doi: 10.1097/BPB.0000000000000090. PubMed 25144885 ↗
  • Thacker MM, Scher DM, Sala DA, van Bosse HJ, Feldman DS, Lehman WB. Use of the foot abduction orthosis following Ponseti casts: is it essential? J Pediatr Orthop. 2005 Mar-Apr;25(2):225-8. doi: 10.1097/01.bpo.0000150814.56790.f9. PubMed 15718907 ↗
  • Ramirez N, Flynn JM, Fernandez S, Seda W, Macchiavelli RE. Orthosis noncompliance after the Ponseti method for the treatment of idiopathic clubfeet: a relevant problem that needs reevaluation. J Pediatr Orthop. 2011 Sep;31(6):710-5. doi: 10.1097/BPO.0b013e318221eaa1. PubMed 21841450 ↗
  • Bouchoucha S, Smida M, Saied W, Safi H, Ammar C, Nessib MN, Ghachem MB. Early results of the Ponseti method using the Steenbek foot abduction brace: a prospective study of 95 feet. J Pediatr Orthop B. 2008 May;17(3):134-8. doi: 10.1097/BPB.0b013e3282fa5f0d. PubMed 18391812 ↗
  • Desai L, Oprescu F, DiMeo A, Morcuende JA. Bracing in the treatment of children with clubfoot: past, present, and future. Iowa Orthop J. 2010;30:15-23. PubMed 21045966 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03249805
Lead sponsor
MiracleFeet
Collaborators
Bai Jerbai Wadia Hospital for Children, Mumbai, India, Metwiz Materials, CURE, Biomedical Engineering and Technology (Incubation) Center, Bombay
Responsible party
Sponsor
First posted
Aug 15, 2017
Start date
Jun 7, 2017
Primary completion
Dec 31, 2018 (estimated)
Completion
Dec 31, 2018 (estimated)
Last update
Aug 17, 2018

Study contacts

Alaric Aroojis, MD
Contact
aaroojis@gmail.com
+91 9320284402
Alaric Aroojis, MD
principal investigator · Bai Jerbai Wadia Hospital for Children

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion